SEC Form 4 · accession 0001209191-18-020355
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shamim Ruff
Officer — SVP, Chief Regulatory Affairs
Period of report
Mar 15, 2018
Accepted (ET)
Mar 16, 2018 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2018 | M | 469 | $13.90 | A | 27,514 | D | |
| Common StockF1 | Mar 15, 2018 | F | 80 | $81.22 | D | 27,434 | D | |
| Common Stock | Mar 15, 2018 | M | 2,031 | $26.24 | A | 29,465 | D | |
| Common StockF1 | Mar 15, 2018 | F | 656 | $81.22 | D | 28,809 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy) | $13.90 | Mar 15, 2018 | M | 469 | D | Feb 27, 2016 | Feb 27, 2025 | Common Stock | 469 | 6,134 | D |
| Stock option (right to buy) | $26.24 | Mar 15, 2018 | M | 2,031 | D | Jan 2, 2014 | Jan 2, 2023 | Common Stock | 2,031 | 10,066 | D |
Explanation of responses
- F1The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person.